For the Inventor, By the Inventor

Enter inventor name

Chula Vista, CA, United States of America

Edward Rockenstein

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 120(Granted Patents)

Location History:

San Diego, CA (US) (2011 - 2012)
Chula Vista, CA (US) (2007 - 2015)
La Jolla, CA (US) (2021)

Company Filing History:

11 out of 15,475

University of California

Neotope Biosciences Limited

Elan Pharmaceuticals, Inc.

Neuropore Therapies, Inc.

Prothena Biosciences Limited

where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947302 - Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them (2021-03-16),

2. 9034337 - Treatment and delay of outset of synucleinopathic and amyloidogenic disease (2015-05-19),

3. 8946165 - Compounds for reversing and inhibiting protein aggregation, and methods for making and using them (2015-02-03),

4. 8846682 - Compound suitable for the treatment of synucleopathies (2014-09-30),

5. 8506959 - Prevention and treatment of synucleinopathic and amyloidogenic disease (2013-08-13),

6. 8450481 - Compounds for inhibiting protein aggregation, and methods for making and using them (2013-05-28),

7. 8147833 - Prevention and treatment of synucleinopathic and amyloidogenic disease (2012-04-03),

8. 8092801 - Prevention and treatment of synucleinopathic and amyloidogenic disease (2012-01-10),

9. 7919088 - Treatment and delay of onset of synucleinopathic and amyloidogenic disease (2011-04-05),

10. 7795495 - Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them (2010-09-14),

11. 7459601 - Human α synuclein expressing transgenic mice (2008-12-02),

12. 7393994 - Transgenic mouse model for neurodegenerative diseases (2008-07-01),

13. 7276643 - Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents (2007-10-02),

14. 7226746 - Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease (2007-06-05),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…